It’s not clear if the Department of Justice will issue a new cannabis prosecution guidance memo under… [new head of DEA, Anne Milgram, former Attorney General of New Jersey]… she has publicly stated her opposition to even modest reforms such as state-level efforts to simply decriminalize marijuana [in the past]… William Barr, maintained that Congress…
…this kind of internalized prohibition “shows how the process of colonialism colonizes not only the land, but the people as well, to become a perpetual machine of oppression against themselves.” …research points to implementation of drug prohibition and penalization policies as a way to “civilize” Indigenous peoples [and “others”]. Over time, these ideas have been…
Francis Collins, director of the National Institutes of Health (NIH) expressed positive remarks about the therapeutic potential of psychedelics such as psilocybin and MDMA. “I think as we’ve learned more about how the brain works we began to realize that these are potential tools for research purposes and might be clinically beneficial,” Collins said. The…
[These removed California psychedelic decriminalization SB 519 sections] would have had a major impact on getting people out of jail for the possession of drugs that look to be on the verge of decriminalization. We’ve seen a lot of family reunification stories in cannabis over the past few years – it will be nice to…
In a friend of the court brief filed… in the U.S. Court of Appeals for the Ninth Circuit, the state attorneys general say DEA’s rejection of the patients’ application was an overreach of the agency’s power… the states’ filing stops short of saying the patients are eligible to use psilocybin under Washington’s state law [for…
Appearing before a congressional panel… December [2020], members of the Sackler family said they had done nothing wrong. “The family and the board acted legally and ethically,” testified David Sackler, who served on Purdue Pharma’s board for six years. This development brings members of the Sackler family, some of whom own Purdue Pharma and served on…
The California state Senate passed SB 519… 21-16 on a floor vote. The bill had already cleared three separate committees and stands a decent chance of passing the House from where it would proceed to the desk of [the] California Governor… [SB 519] does not decriminalize the sale of psychedelics in the state [but allows…
The survey found younger voters to be more likely to say psychedelic substances have medical uses… Fifty-three percent of 18-29 year olds said “magic mushrooms” have medicinal benefits while majorities of voters 30 and older said they do not… the 2020 election saw several states ease restrictions on recreational drug use. Original Article (The Hill):Poll:…
With a growing body of research showing that psychedelic substances have potential medical uses, local governments across the US have begun to take notice. A study from Imperial College London scientists released in April, for example, found that psilocybin… works about as well as a leading drug (escitalopram) to treat patients with moderate or severe major depressive…
For psilocybin specifically, the legislation would repeal provisions in California statute that prohibit the cultivation or transportation of “any spores or mycelium capable of producing mushrooms or other material” that contain the psychoactive ingredient… …this means the psychedelics reform measure will be taken up by the full chamber by June 4, 2021. If it passes…
Recent Comments